SCHEMBL476857

SCHEMBL476857

COc1ccccc1P(c1ccccc1)c1ccccc1OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 4/20 0.50
CA2 P00918 4/20 0.50
CA7 P43166 3/20 0.50
CA9 Q16790 3/20 0.50
CA12 O43570 2/20 0.50
CA14 Q9ULX7 2/20 0.50
CA4 P22748 2/20 0.50
TDP1 Q9NUW8 3/20 0.46
CYP3A4 P08684 1/20 0.46
ALDH1A1 P00352 3/20 0.41
TP53 P04637 1/20 0.41
TSHR P16473 1/20 0.41
ADRA2B P18089 1/20 0.41
PTGS1 P23219 1/20 0.41
MAPK1 P28482 1/20 0.40
HTT P42858 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
ENPP2 Q13822 1/20 0.39
TRPA1 O75762 1/20 0.38
NFE2L2 Q16236 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30992110 1.00 CA1 (0.50) CA1CA2CA7CA9CA12
SCHEMBL8459532 0.98 CA1 (0.48) CA1CA2CA7CA9CA12
SCHEMBL56425 0.96 CA1 (0.50) CA1CA2CA7CA9CA12
SCHEMBL16487755 0.91 CA1 (0.41) CA1CA2CA7CA9CA12
SCHEMBL14603737 0.89 CA1 (0.40) CA1CA2CA7CA9CA12
SCHEMBL14603736 0.89 CA1 (0.40) CA1CA2CA7CA9CA12
SCHEMBL28200386 0.89 CA1 (0.40) CA1CA2CA7CA9CA12
SCHEMBL14604235 0.89 CA1 (0.40) CA1CA2CA7CA9CA12
SCHEMBL14604098 0.88 CA1 (0.39) CA1CA2CA7CA9CA12
SCHEMBL14604085 0.88 CA1 (0.39) CA1CA2CA7CA9CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 179 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2321244-B1 IMPROVED PROCESS FOR TELOMERIZATION OF BUTADIENE DOW GLOBAL TECHNOLOGIES LLC (US) 2016-12-21 EP claimed
US-8558030-B2 Process for telomerization of butadiene DOW GLOBAL TECHNOLOGIES LLC (US) 2013-10-15 US claimed
US-20110137086-A1 PROCESS FOR TELOMERIZATION OF BUTADIENE Dow Global Technologies LLC (Formerly known as Dow Global Technologies Inc.) (US) 2011-06-09 US claimed
EP-2321244-A2 AN IMPROVED PROCESS FOR TELOMERIZATION OF BUTADIENE Dow Global Technologies LLC (US) 2011-05-18 EP claimed
WO-2010019360-A2 AN IMPROVED PROCESS FOR TELOMERIZATION OF BUTADIENE DOW GLOBAL TECHNOLOGIES INC. (US) 2010-02-18 WO claimed
JP-1009994-A None JP disclosed
US-12617952-B1 Self-ameliorate-fissure-responsive pod system for alkyd-polyester aircraft runway paint UNIVERSITY OF TABUK (SA) 2026-05-05 US disclosed
EP-4101892-B1 COMPOSITION, THERMALLY CONDUCTIVE MATERIAL, THERMALLY CONDUCTIVE SHEET, AND DEVICE WITH THERMALLY CONDUCTIVE LAYER FUJIFILM CORP (JP) 2024-02-21 EP disclosed
US-20230020941-A1 COMPOSITION, THERMALLY CONDUCTIVE MATERIAL, THERMALLY CONDUCTIVE SHEET, AND DEVICE WITH THERMALLY CONDUCTIVE LAYER FUJIFILM CORPORATION (JP) 2023-01-19 US disclosed
EP-4101892-A1 COMPOSITION, THERMALLY CONDUCTIVE MATERIAL, THERMALLY CONDUCTIVE SHEET, AND DEVICE WITH THERMALLY CONDUCTIVE LAYER FUJIFILM Corporation (JP) 2022-12-14 EP disclosed
EP-2735581-B1 COMPOSITION AND POLYMER ASAHI CHEMICAL IND (JP) 2021-07-14 EP disclosed
EP-2990112-B1 METHOD FOR MANUFACTURING CATALYST FOR SYNTHESIZING CYCLIC CARBONATE MARUZEN PETROCHEM CO LTD (JP) 2020-03-25 EP disclosed
US-5084536-A Reaction product of olefinically unsaturated compounds with compounds containing active hydrogen, processes for their preparation and 2-component lacquers based thereon HOECHST AG (DE) 1992-01-28 US disclosed
EP-0310011-B1 CURING AGENT AND ITS USE HOECHST AKTIENGESELLSCHAFT (DE) 1991-07-24 EP disclosed
US-4871822-A Reaction product of olefinically unsaturated compounds with compounds containing active hydrogen, processes for their preparation and 2-component lacquers based thereon HOE 85/F O36J HOECHST AG (DE) 1989-10-03 US disclosed
EP-0160824-B1 REACTION PRODUCT OF OLEFINICALLY UNSATURATED COMPOUNDS WITH ACTIVE HYDROGEN COMPOUNDS, PROCESS FOR THEIR PREPARATION AND 2-COMPONENT COATING SYSTEMS BASED THEREON HOECHST AKTIENGESELLSCHAFT (DE) 1989-09-06 EP disclosed
EP-0310011-A1 Curing agent and its use HOECHST AKTIENGESELLSCHAFT (DE) 1989-04-05 EP disclosed
EP-0294000-A2 Novel diaryl phosphides SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) 1988-12-07 EP disclosed
EP-0224158-A2 Hardenable mixture based on olefinically unsaturated compounds and active hydrogen-containing compounds. HOECHST AKTIENGESELLSCHAFT (DE) 1987-06-03 EP disclosed
EP-0160824-A1 Reaction product of olefinically unsaturated compounds with active hydrogen compounds, process for their preparation and 2-component coating systems based thereon HOECHST AKTIENGESELLSCHAFT (DE) 1985-11-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110137086-A1 PROCESS FOR TELOMERIZATION OF BUTADIENE HRH3, HRH4, TELO2 CA1 4615/4885CA2 3509/4885CA7 3055/4885
US-12617952-B1 Self-ameliorate-fissure-responsive pod system for alkyd-polyester aircraft runway paint PARG, PLOD3, PARN CA1 4739/4885CA2 3402/4885CA7 4321/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.